We protect your health through science
Investigation
Human Papillomavirus
Publications
Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection
Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection. Vigón L, Rodríguez-Mora S, Luna A, Sandonís V, Mateos E, Bautista G, Steegmann JL, Climent N, Plana M, Pérez-Romero P, de Ory F, Alcamí J, García-Gutierrez V, Planelles V, López-Huertas MR, Coiras M (AC). Biochem Pharmacol. 2020 Dec;182:114203. doi: 10.1016/j.bcp.2020.114203. PMID: 32828803.
PUBMED DOITyrosine Kinase Inhibition: a New Perspective in the Fight against HIV
Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV. Rodríguez-Mora S, Spivak AM, Szaniawski MA, López-Huertas MR, Alcamí J, Planelles V, Coiras M (AC). Curr HIV/AIDS Rep. 2019 Oct;16(5):414-422. doi: 10.1007/s11904-019-00462-5. PMID: 31506864. Review.
PUBMED DOIDasatinib protects humanized mice from acute HIV-1 infection
Dasatinib protects humanized mice from acute HIV-1 infection. Salgado M, Martinez-Picado J, Gálvez C, Rodríguez-Mora S, Rivaya B, Urrea V, Mateos E, Alcamí J, Coiras M (AC). Biochem Pharmacol. 2020 Apr;174:113625. doi: 10.1016/j.bcp.2019.113625. PMID: 31476293.
PUBMED DOIEvaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors.
Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors. Bermejo M, Ambrosioni J, Bautista G, Climent N, Mateos E, Rovira C, Rodríguez-Mora S, López-Huertas MR, García-Gutiérrez V, Steegmann JL, Duarte R, Cervantes F, Plana M, Miró JM, Alcamí J, Coiras M (AC). Biochem Pharmacol. 2018 Oct;156:248-264. doi: 10.1016/j.bcp.2018.08.031. PMID: 30142322.
PUBMED DOIAdditional Information
Diagnosis/Reference: detection and genotyping of the Human Papillomavirus, tests offered at https://cnm-laboratorios.isciii.es/.
For additional studies contact the laboratory.
• Molecular epidemiology of infections caused by HPV in the general population and in different risk groups.
• Surveillance of the distribution of genotypes in the population to monitor the effectiveness of vaccination against HPV.
• Development of new methodology for the diagnosis and characterization of infections caused by HPV.
Diagnosis/Reference: detection and genotyping of the Human Papillomavirus, tests offered at https://cnm-laboratorios.isciii.es/.
For additional studies contact the laboratory.
• Molecular epidemiology of infections caused by HPV in the general population and in different risk groups.
• Surveillance of the distribution of genotypes in the population to monitor the effectiveness of vaccination against HPV.
• Development of new methodology for the diagnosis and characterization of infections caused by HPV.